Pharma's mammoth immunology market? It's only getting bigger: analysts

4th April 2019 Uncategorised 0

The autoimmune and inflammatory markets have witnessed some of the best-selling drugs, but despite generally being considered crowded, the market still has a lot of room for growth, a team of Credit Suisse analysts said in a Wednesday note to clients.  

More: Pharma's mammoth immunology market? It's only getting bigger: analysts
Source: fierce